ArticleBMC oral health2026
Cariostatic effects of pediatric iron supplement formulations on streptococcus mutans-induced enamel demineralization: an in vitro study.
Article in BMC oral health, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
8 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
backgroundIron deficiency anemia (IDA) is one of the most prevalent nutritional disorders in childhood, and oral iron supplements remain the standard therapy. Experimental evidence suggests that iron may inhibit cariogenic activity; however, the in-vitro cariostatic potential of commonly prescribed pediatric iron formulations remains insufficiently characterized.
objectiveTo evaluate the in vitro cariostatic potential of four commercially available pediatric iron supplements on Streptococcus mutans–induced enamel demineralization using permanent human premolars. MATERIALS AND
methodsA total of 120 extracted sound permanent human premolars were randomly allocated into six groups (n = 20): four iron supplement groups (Fre-in-sol, Ferotonic, Feromin, Ferose), a positive control (S. mutans + 10% sucrose), and a negative control. Artificial caries lesions were induced using S. mutans (strain 6715) with 10% sucrose under anaerobic conditions for 60 days. Enamel demineralization was assessed daily using ICDAS-II visual criteria, tactile examination, and DIAGNOdent laser fluorescence. Incidence data were analyzed using Chi-square or Fisher’s exact tests (α = 0.05), while DIAGNOdent values and time-to-onset were summarized descriptively and analyzed statistically where applicable.
resultsAll specimens in the positive control group developed enamel demineralization by day 12 (20/20, 100%). In contrast, Fre-in-sol (2/20, 10%), Ferotonic (3/20, 15%), and Feromin (3/20, 15%) groups showed significantly reduced demineralization incidence compared with the positive control (p < 0.001), with delayed mean onset ranging from 29 to 47 days. The Ferose group demonstrated higher demineralization (16/20, 80%) and did not differ significantly from the positive control (p = 0.053). Mean end-of-study DIAGNOdent readings were lowest for Fre-in-sol (8.4 ± 2.3), Ferotonic (9.7 ± 2.6), and Feromin (9.1 ± 2.4), highest for the positive control (38.6 ± 4.1), and intermediate for Ferose (24.9 ± 3.8). Cavitation was observed only in the positive control (20%) and Ferose (5%) groups.
conclusionWithin the limitations of this in vitro study, ferrous sulfate–based pediatric iron formulations showed greater inhibition of S. mutans–induced enamel demineralization than ferric polymaltose. These findings indicate a formulation-dependent in vitro cariostatic potential and support further investigation under clinical conditions. CLINICAL SIGNIFICANCE: Certain pediatric iron supplements showed in vitro cariostatic effect and could potentially provide inhibition effect for caries activity in addition to correcting anemia. However, pediatric clinical studies are required before recommendations regarding formulation selection can be made.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.